OCULUS Keratograph 5M debuts colour to topography!

Article

Keratograph 5M technology is a revolution in corneal topography and dry eye analysis. The high-resolution colour camera and the integrated magnification changer offer a new perspective on the tear film assessment procedure.

The new Keratograph 5M is the perfect tool for topography and advanced external imaging for dry eye screening.

  • High-resolution colour camera and magnification changer
  • Imaging of the upper and lower meibomian glands
  • Non-invasive tear film break up time and tear meniscus height measurements
  • Assessment of the lipid layer and tear film particles
  • Grading of the bulbar redness
  • Image and video documentation

The high-resolution colour camera and the integrated magnification changer of the OCULUS Keratograph 5M offer a new perspective on the tear film assessment procedure.

The Keratograph 5M provides the ideal illumination for every application: white diodes for the assessment of tear film particles movement, blue diodes for fluorescein imaging, infrared diodes for meibography and white annular illumination is used to precisely measure thousands of points on the surface of the cornea.

In addition to these unique features the Keratograph 5M measures corneal topography precisely. The built-in real keratometer and automatic measurement activation guarantee perfect reproducibility of K values. Tear film break-up time measurement with the Keratograph 5M is touch-free and fully automatic.

Integrate the Keratograph 5M into your practice as an active patient consultation tool. Thanks to many visual maps and easy to understand diagrams the Keratograph 5M enhances communication with your patients.

Further information may be found here.

Company DetailsE-mail: export@oculus.deWebsite: www.oculus.de

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.